Lv42
600 积分 2023-04-04 加入
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
1天前
已完结
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
4天前
已完结
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
4天前
已完结
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
7天前
已完结
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts
1个月前
已完结
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations
10个月前
已完结
Statistical considerations for some issues in clinical bridging studies evaluating companion diagnostic devices
1年前
已完结
Statistical considerations for some issues in clinical bridging studies evaluating companion diagnostic devices
1年前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1年前
已完结
Mirvetuximab Soravtansine: First Approval
1年前
已完结
皖公网安备34019202002308
